Latest News All the latest and greatest healthcare news

Utilize our RSS Feeds for expert insight and news on the healthcare industry, people on the move, and thought leadership articles regarding career management, interview tips, and recruitment trends. Have some news to contribute? Join the conversation by contacting Academic Med.

Dr. Vivian Tabar selected as Neurosurgery Chair at Memorial Sloan Kettering

Dr. Vivian Tabar, selected as Chair of Neurosurgery at Memorial Sloan Kettering Cancer Center 

Congatulations to Vivian Tabar, MD, the newly appointed Chair, Department of Neurosurgery at the Memorail Sloan Kettering Cancer Center (MSK)!

Dr. Tabar is a neurosurgeon and stem cell biologist that's been selected to run the esteemed Neurosurgery Department after serving as a vital faculty member at MSK for more than 15 years. She is currently the Theresa C. Feng Chair for Neurosurgical Oncology and the Vice Chair for Neurosurgical Research and Education. 

Dr. Tabar received her medical degree from the American University of Beirut, completed a neurosurgical residency at the University of Massachusetts, and joined MSK as a clinical fellow. After conducting her postdoctoral work at the National Institutes of Neurological Disorders and Stroke, she returned to MSK to complete a research fellowship before joining the faculty. Her work has been published extensively, and she is the recipient of numerous awards, including from the American Association of Neurological Surgery and the American Brain Tumor Association. Dr. Tabar is an elected member of the American Society for Clinical Investigation, the Society of Neurological Surgeons, and, most recently, the National Academy of Medicine.

A distinguished surgeon-scientist, Dr. Tabar focuses her research on stem cell biology. She is the co-leader of the New York State consortium for the development of human embryonic stem cell–derived dopamine neurons for Parkinson’s disease. She has also developed strategies for cell-based therapies for the repair of radiation-induced brain injury. Dr. Tabar’s lab pioneered the use of pluripotent stem cells for brain tumor modeling, leading to novel insights into the biology of gliomas and to the discovery of candidate therapeutic targets for the disease.

Dr. Tabar succeeds Philip Gutin, MD, who retired at the end of 2017. 

 

Article References:

http://www.onclive.com/sap-partner/cancer-centers/mskcc/viviane-tabar-md-named-chair-of-the-department-of-neurosurgery-at-memorial-sloan-kettering-cancer-center

http://bluerocktx.com/team/viviane-tabar-m-d/

https://www.mskcc.org/press-releases/viviane-tabar-md-named-chair-department-neurosurgery-msk-cancer

 

+ share